Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "nośniki" wg kryterium: Temat


Wyświetlanie 1-3 z 3
Tytuł:
Wpływ reszt ΔPhe na konformację łańcucha peptydowego
Influence of ΔPhe residues on Conformation of peptide chain
Autorzy:
Ledwoń, Patrycja
Staśkiewicz, Agnieszka
Jewgiński, Michał
Latajka, Rafał
Powiązania:
https://bibliotekanauki.pl/articles/171962.pdf
Data publikacji:
2020
Wydawca:
Polskie Towarzystwo Chemiczne
Tematy:
dehydroaminokwasy
dehydrofenyloalanina
nośniki leków
dehydroamino acids
dehydrophenylalanine
drug carriers
Opis:
In the past few years dehydropeptides have been highly investigated, mainly due to their biological activity: for instance, as antimicrobials or catalytic agents in some enzymes [1, 51-53]. In presented studies it was established that dehydrophenylalanine residue (ΔPhe) can be an interesting building block of various peptide chains, in order to control and modify a structure, conformation and function of the target molecule [3, 4, 5-7]. It was also pointed out that the length of a linker between dehydroamino acid residues (if two or more are present in a peptide chain) is a crucial factor in case of conformational dependence [23]. Short, one-residue spacers promote 310-helical structure, while longer ones increase the coexistence of 310-helical and α-helical conformers (Table 7). What is worth to notice, temperature or polarity of solvent can dramatically change the screw sense of obtained 310-helices (Table 11). Additionally, the screw sense can be altered by other variables, like chirality of C and N-terminus or dehydroamino acid isomer type (E or Z) [4-11]. Considering chain conformation, it can be disparate, depending on environment’s solid or liquid state (Table 7). Application of dehydropeptides is widely spread among assorted field of studies. As they can form a few self-assembled structures (e.g. nanotubes, nanovesicles or hydrogels), arise an opportunity of encapsulation of small drug molecules or trapping and releasing bioactive substances [47-49]. Sequences with incorporated dehydroamino acid residues were examined as a potential drug - interaction with negatively charged membrane of bacteria species is possible by virtue of positive polarization of peptide chain [51]. Part of the sequences exert an activity against E. coli, S. aureus, P. falciparum or highly dangerous MRSA, presenting versatile potential correlated with their secondary structure [50-53].
Źródło:
Wiadomości Chemiczne; 2020, 74, 1-2; 9-32
0043-5104
2300-0295
Pojawia się w:
Wiadomości Chemiczne
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Nowe rozwiązania i modyfikacje najpopularniejszych polimerowych nośników substancji aktywnych
New solutions and modifications of the most popular polymeric carriers of active substances
Autorzy:
Odrobińska, Justyna
Neugebauer, Dorota
Powiązania:
https://bibliotekanauki.pl/articles/171574.pdf
Data publikacji:
2019
Wydawca:
Polskie Towarzystwo Chemiczne
Tematy:
koniugaty
micele
liposomy
nanocząstki
nośniki polimerowe
conjugates
micelles
liposomes
nanoparticles
polymeric carriers
Opis:
The progress of medicine and cosmetology corresponds to the increase in the need for new drug design and delivery methods, due to the already common cancer risk, as well as other diseases, which are still difficult for curing. Regardless of the type of active substance and its final application, the selection and synthesis of the appropriate carrier is crucial to provide the pharmaceutics to the target with the controlled release for a set period of time, including the intelligent activity. Depending on the way the bioactive substance is bound to carriers in the drug delivery systems (DDS) they are classified onto: carriers that physically encapsulate them inside i.e. liposomes, solid lipid nanoparticles, nanostructural lipid carriers, nanoparticles (nanocapsules, nanospheres), micelles, and carriers that chemically bind the active substance, i.e. conjugates, polyplexes. The current studies are emphasized to achieve the most perfect improvement, which concerns the efficiency of encapsulation, the ability to deliver several compounds simultaneously or sequentially, the productive release, the elimination of side products, the replacement of synthetic polymers by natural, biodegradable, biocompatible and non-toxic polymers. These carriers are also developed in terms of sensitivity to stimuli (one or several simultaneously or sequentially activated) and adapted for combined therapy. Although the subject of active substance delivery with the use of carriers is already widely studied, these are still a needs for the designing of new or the enhancement of the already known DDS. Working on this issue there is hope that today still incurable diseases, neoplastic diseases, as well as the diagnosis of these diseases themselves, will be possible to control and treat in the future. This report presents the current state of the knowledge in the area of DDS, focusing on newly developed solutions in the last years.
Źródło:
Wiadomości Chemiczne; 2019, 73, 9-10; 481-501
0043-5104
2300-0295
Pojawia się w:
Wiadomości Chemiczne
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Nieorganiczne nanocząstki w medycynie nuklearnej
Inorganic nanoparticles in nuclear medicine
Autorzy:
Kasperek, A.
Bilewicz, A.
Powiązania:
https://bibliotekanauki.pl/articles/172564.pdf
Data publikacji:
2012
Wydawca:
Polskie Towarzystwo Chemiczne
Tematy:
nanocząstki
medycyna nuklearna
system transportu leków
nośniki leków
nanoparticles
nuclear medicine
drug delivery systems
drug carriers
Opis:
Rapid and widespread growth in the use of nuclear medicine for both diagnosis and therapy of disease has been the driving force for a design of novel radiopharmaceuticals. Particularly, recent progress in nanotechnology gives the possibility of designing new carriers for delivering radionuclides in a manner to overcome some limitation such as nonspecific biodistribution and targeting, water insolubility, poor oral bioavailability and others. There are several perspective therapeutic and diagnostic radionuclides which cannot be bound to biomolecule via chemical bonds. Nanocarriers gives the opportunity for binding such radionuclides. Nanoparticles have to be designed with an optimal size (above 100 nm) and surface characteristic to easily penetrate the barriers in the body and prevent elimination by reticuloendothelial system. Among nanoparticles which are used for delivery and targeting are polymers, lipids, viruses, organometallic compounds, precious metals or metal oxides. This article presents a brief review of the applications, advantages, difficulties and future perspective of inorganic nanoparticles, which can be used as radionuclide delivery systems. The main direction of developing new nanostructures for nuclear medicine is to create multimodal agents which are suitable for such combined methods as PET /MRI or PET /NIRF. Also combination of diagnostic and therapeutic agents in one nanocontainer is possible.
Źródło:
Wiadomości Chemiczne; 2012, 66, 7-8; 697-714
0043-5104
2300-0295
Pojawia się w:
Wiadomości Chemiczne
Dostawca treści:
Biblioteka Nauki
Artykuł
    Wyświetlanie 1-3 z 3

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies